On the other hand, Jiang et al. have found that high expression levels of PPARγ were associated with long patients’ overall survival, suggesting the clinical relevance of this receptor as a prognostic indicator potentially targetable for the development of novel treatments in breast cancer [41]. The gene discussed is PPARG; the disease is breast carcinoma.